---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-082071"
form_type: "8-K"
ticker: null
cik: "0001796129"
company_name: "Vincerx Pharma, Inc."
filed_at: "2024-03-29T23:59:59+00:00"
generated_at: "2026-06-04T05:29:56.820816+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Vincerx Pharma enters $50M ATM equity offering agreement with Leerink Partners

## Summary
- Up to $50M of common stock may be sold at-the-market through Leerink Partners as agent.
- Commission of 3.0% of gross proceeds payable to Leerink; no obligation to sell any shares.
- Sales occur under existing S-3 shelf registration (filed Jan 2022, effective Jan 2022).
- Company may suspend or terminate sales at any time; either party may terminate the agreement.

## SEC filing metadata
- accession: 0001193125-24-082071
- form_type: 8-K
- cik: 0001796129
- company_name: Vincerx Pharma, Inc.
- filed_at: 2024-03-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1796129/000119312524082071/0001193125-24-082071-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1796129/000119312524082071/d819653d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-082071
- JSON: https://secwatch.observer/filing/0001193125-24-082071.json
- Plain text: https://secwatch.observer/filing/0001193125-24-082071.txt

## Key facts
- Material Agreements
  Vincerx Pharma, Inc. entered into Sales Agreement with Leerink Partners LLC valued at up to $50,000,000 (effective 2024-03-29).
  - Action: entry
  - Agreement: atm program
  - Counterparty: Leerink Partners LLC
  - Value: up to $50,000,000
  - Effective: 2024-03-29
  source text: On March 29, 2024, Vincerx Pharma, Inc. (the “Company”) entered into a Sales Agreement (the “Agreement”) with Leerink Partners LLC (the “Sales Agent”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1796129/000119312524082071/0001193125-24-082071-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.